Sustained-release liquisolid compact tablets containing artemether–lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance

The present study aimed to develop low-dose liquisolid tablets of two antimalarial drugs artemether–lumefantrine (AL) from a nanostructured lipid carrier (NLC) of lumefantrine (LUM) and estimate the potential of AL as an oral delivery system in malariogenic Wistar mice. LUM-NLCs were prepared by hot...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Int J Nanomedicine
Κύριοι συγγραφείς: Nnamani, Petra Obioma, Ugwu, Agatha Adaora, Ibezim, Emmanuel Chinedu, Kenechukwu, Franklin Chimaobi, Akpa, Paul Achile, Ogbonna, John-Dike Nwabueze, Obitte, Nicholas Chinedu, Odo, Amelia Ngozi, Windbergs, Maike, Lehr, Claus-Michael, Attama, Anthony Amaechi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Dove Medical Press 2016
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135285/
https://ncbi.nlm.nih.gov/pubmed/27932882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S92755
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια